Carrión-Barberà, María Irene; Fajardo, Melissa; Danias, George; Tsapepas, Demetra; Gartshteyn, Yevgeniya; Fernández, Hilda; Askanase, Anca
(BMJ Publishing Group, 2019)
Objectives: Lupus nephritis (LN) requires renal replacement therapy in 10%-30% of patients. About 30% of these patients receive a kidney transplant. Belatacept is a second-generation, selective, T-cell co-stimulator blocker ...